- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar gains multiple-scanning patent
MRI developer Fonar of Melville, NY, has been issued another patent, this one for a novel software module designed to work with MRI scanners using multiple patient beds. The software is designed to increase the productivity of scanners using the
MRI developer Fonar of Melville, NY, has been issued another patent, this one for a novel software module designed to work with MRI scanners using multiple patient beds. The software is designed to increase the productivity of scanners using the multiple-bed configuration by allowing several scans to be conducted on the same machine simultaneously, according to a Fonar spokesperson.
MRI scanners in Fonar's new Quad line are open on all four sides, enabling patient beds to be attached to a scanner at any of the openings. Fonar last year received a patent for the technology (SCAN 4/24/96), which the company hopes will help it provide exams such as MRI breast screening at a cost of $80 to $150 per exam.
Last month's patent covers software that essentially allows the MRI scanner to keep up with the higher levels of throughput possible with the multiple-bed configuration, according to the spokesperson. It can, however, be used with all MRI scanners, not just the Quad line.
The software allows two or more patients to be scanned simultaneously, while a privacy shield can be installed in the scanner so that the patients feel they are receiving individual scans. The software should reduce scanner downtime and make MRI operation more efficient, according to Fonar.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
